We propose that the increase in IL-10 production by B cells functions as a counter mechanism to limit inflammation in an environment in which homeostatic functions of sIgM are missing temporally or spatially, such as early in life or within tissues, or permanently as in patients with selective IgM deficiency. This evidence concerns the gene CD40LG and hyperinsulinemic hypoglycemia, familial, 4.